Joan Seoane Archives

A possible new combination of treatments to combat cancer

A new joint effort by the Hospital del Mar Research Institute, the Vall d’Hebron Institut d’Oncologia (VHIO), IDIBELL, and the…

Under the review spotlight: the promise of combined preclinical cancer modelling in immuno-oncology

In an invited Viewpoint article recently published open access and ahead of print in the journal Molecular Oncology*, VHIO’s Joan…

Recent studies show that MSC-1 LIF blockade is safe and well tolerated in patients with advanced solid tumors and point to LIF as a as a novel drug target in immune-oncology

Published in ESMO Open, results of a phase I first-in-human study co-authored by investigators at the Vall d’Hebron Institute of…

Novel T cell bispecific antibody shows potent anti-tumor activity in preclinical models of epidermal growth factor receptor variant III (EGFRvIII) mutant glioblastoma

Published in Molecular Cancer Therapeutics*, a journal of the American Association for Cancer Research (AACR), results of a study co-led…

Counting down to World Cancer Research Day, 24 September: lend your support to this year’s campaign entitled Cancer Research Works, Driving Progress Together

Barcelona, August 24, 2021. Launched back in 2016 by Spanish Association against Cancer (AECC), and organized in collaboration with the…

Immune cells in cerebrospinal fluid: predictors of response to immunotherapy against brain metastasis

The analysis of immune cells infiltrating cerebrospinal fluid enables the characterization of the tumor microenvironment in brain metastases. Findings reported today in…

Proof-of-concept study points to the placenta as a protective barrier against COVID-19 during pregnancy

Findings from a comprehensive clinical, morphological, and molecular analysis of a cohort of 37 pregnant women with and without SARS-CoV-2…